Laparoscopic Devices – Market Insights – United States

The US laparoscopic device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent modest expansion through 2032. Although the market will continue to shift toward MIS, robotic-assisted procedures will account for an increasing proportion of minimally invasive procedures performed in the US going forward, limiting demand for traditional multiport laparoscopy, although the lack of additional reimbursement for robotic-assisted procedures will hinder the pace of RAS procedure volume growth to some extent. Demand for devices designed for robotic procedures, such as robotic trocars and hand instruments, will increase rapidly, supporting market expansion due to the higher prices associated with these advanced devices, as will the continued adoption of other innovative, premium-priced technologies, such as direct energy devices, powered staplers, and 4K video laparoscopes.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for laparoscopic devices in the US from 2019 through 2032.

Rapidly expanding robotic-assisted procedure volumes will support overall growth in the laparoscopic device market.

How are robotic systems affecting laparoscopic and open procedure volumes?

Which competitors are currently able to market surgical robots in the US?

What technological advancements are companies looking to offer in their laparoscopic surgical robotic devices in the coming years?

Robotic-assisted procedures will account for an increasing proportion of MIS, limiting demand for traditional laparoscopy.

Which procedure types have the highest and lowest laparoscopic technique penetration amid the growing influence of robotic surgery?

Given the rise of robotic surgery, which laparoscopic procedures are still growing, and which ones are nearing saturation?

Which technique—open or laparoscopic—is more affected by the rise of robotic surgery?

Adoption of premium-priced technologies is driving growth in the laparoscopic device market.

Which device segments will show the strongest growth in the US?

Which technologies will see increasing physician adoption during the forecast period?

The No Surprises Act was enacted in early 2022.

How will this impact emergency laparoscopic procedure volumes?

The FDA issued a final order reclassifying surgical staplers from Class I to Class II.

What are the impacts of this order on key competitors?

How does this affect growth in the internal closure device segment?

Significant changes were made to CPT reimbursement for anterior abdominal hernia repair.

What were the changes introduced by recent CMS coding updates for anterior abdominal hernia repair procedures?

What are the implications of altered CPT reimbursement on hernia repair procedure volumes?

Table of contents